Your search returned 2 results.

Results
	1.	Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. MedStar authors: Shorr, Andrew F PMID: 26316562 Year: 2015 Citation: Clinical Infectious Diseases. 61 Suppl 2:S87-93, 2015 Sep 15. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barriere SL, Corey GR, Hardin TC, Lacy MK, Luke DR, Nogid B, Shorr AF, Stryjewski ME, Wang W DOI: http://dx.doi.org/10.1093/cid/civ536 Add to cart (remove)
	2.	A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study. MedStar authors: Shorr, Andrew F PMID: 30685333 Year: 2019 Citation: Chest. 155(6):1119-1130, 2019 06. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Journal Article Form of publication: Journal Article All authors: Fan W, Nathanson BH, Shorr AF, Sulham K, Zilberberg MD DOI: https://dx.doi.org/10.1016/j.chest.2018.12.024 Add to cart (remove)

Refine your search